Whether such screening reduces the risk of stroke and other hard clinical endpoints remains to be seen, say investigators.

What to make of the registry findings is debatable, but a mortality signal in PAD patients with claudication raised eyebrows.

The single-center data, based on echocardiography, reinforce the need for cautious procedural planning in certain subsets.

Health workers going to patients’ houses and nurses prescribing medications were key aspects of the program’s success.

MADRID, Spain—Adding evolocumab (Repatha; Amgen) to statin therapy does not lower the risk of saphenous vein graft (SVG) ...

Earlier, less-invasive treatment is at the core of the latest iteration of the joint European Society of Cardiology/European ...

The data do, however, hint at the benefit of a more tailored approach focusing on groups with higher bleeding risks.

Mamas Mamas talks to Jacob Thomsen Lønborg about how PCI affects outcomes for patients with stable CAD undergoing TAVI.

The REFINE-ICD results highlight the need to find better ways to identify at-risk patients who might benefit, one expert says ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...

In the phase III trial, the monthly injectable lowered levels by nearly 60 percentage points vs placebo, but will it impact events?